Ontology highlight
ABSTRACT: Background
To allow a return to a pre-COVID-19 lifestyle, virtually every country has initiated a vaccination program to mitigate severe disease burden and control transmission. However, it remains to be seen whether herd immunity will be within reach of these programs.Methods
We developed a data-driven model of SARS-CoV-2 transmission for China, a population with low prior immunity from natural infection. The model is calibrated considering COVID-19 natural history and the estimated transmissibility of the Delta variant. Three vaccination programs are tested, including the one currently enacted in China and model-based estimates of the herd immunity level are provided.Results
We found that it is unlike to reach herd immunity for the Delta variant given the relatively low efficacy of the vaccines used in China throughout 2021, the exclusion of underage individuals from the targeted population, and the lack of prior natural immunity. We estimate that, assuming a vaccine efficacy of 90% against the infection, vaccine-induced herd immunity would require a coverage of 93% or higher of the Chinese population. However, even when vaccine-induced herd immunity is not reached, we estimated that vaccination programs can reduce SARS-CoV-2 infections by 53-58% in case of an epidemic starts to unfold in the fall of 2021.Conclusions
Efforts should be taken to increase population's confidence and willingness to be vaccinated and to guarantee highly efficacious vaccines for a wider age range.
SUBMITTER: Liu H
PROVIDER: S-EPMC8328074 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature
Liu Hengcong H Zhang Juanjuan J Cai Jun J Deng Xiaowei X Peng Cheng C Chen Xinghui X Yang Juan J Wu Qianhui Q Chen Xinhua X Chen Zhiyuan Z Zheng Wen W Viboud Cécile C Zhang Wenhong W Ajelli Marco M Yu Hongjie H
medRxiv : the preprint server for health sciences 20210914
<h4>Background</h4>To allow a return to a pre-COVID-19 lifestyle, virtually every country has initiated a vaccination program to mitigate severe disease burden and control transmission. However, it remains to be seen whether herd immunity will be within reach of these programs.<h4>Methods</h4>We developed a data-driven model of SARS-CoV-2 transmission for China, a population with low prior immunity from natural infection. The model is calibrated considering COVID-19 natural history and the estim ...[more]